These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31972562)

  • 1. Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty.
    Kirkgoz T; Karakoc-Aydiner E; Bugrul F; Yavas Abali Z; Helvacioglu D; Kiykim A; Bilgic Eltan S; Aruci Kasap N; Baris S; Ozen A; Guran T; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(1):66-72. PubMed ID: 31972562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature.
    Ökdemir D; Hatipoğlu N; Akar HH; Gül Ü; Akın L; Tahan F; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):923-5. PubMed ID: 25719301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.
    Lam C; Tjon J; Hamilton J; Ahmet AH
    Pharmacotherapy; 2006 Dec; 26(12):1811-5. PubMed ID: 17125443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
    Vurallı D; Alikaşifoğlu A; İyigün İ; Canoruç D; Ozon A; Gönç N; Kandemir N
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):37-44. PubMed ID: 31347350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children.
    Metbulut AP; Adıgüzel KT; İslamoğlu C; Boyraz M; Mısırlıoğlu ED
    Indian J Endocrinol Metab; 2021; 25(6):527-531. PubMed ID: 35355908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
    Bertelloni S; Baroncelli GI; Ferdeghini M; Menchini-Fabris F; Saggese G
    Eur J Pediatr; 2000 May; 159(5):369-74. PubMed ID: 10834524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precocious puberty in children with myelomeningocele: treatment with gonadotropin-releasing hormone analogues.
    Trollmann R; Strehl E; Dörr HG
    Dev Med Child Neurol; 1998 Jan; 40(1):38-43. PubMed ID: 9459215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia after treatment of long-acting gonadotropin-releasing hormone analogue Decapeptyl in girls with central precocious puberty.
    Kauschansky A; Nussinovitch M; Frydman M; Yeshaya A; Ben-Rafael Z
    Fertil Steril; 1995 Aug; 64(2):285-7. PubMed ID: 7615104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues.
    Jensen AM; Brocks V; Holm K; Laursen EM; Müller J
    J Pediatr; 1998 Jan; 132(1):105-8. PubMed ID: 9470009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
    Schmidt H; Kiess W
    J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
    Nam HK; Kim HR; Rhie YJ; Lee KH
    J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study.
    Martinerie L; de Mouzon J; Blumberg J; di Nicola L; Maisonobe P; Carel JC;
    Horm Res Paediatr; 2020; 93(9-10):529-538. PubMed ID: 33774631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.